33 related articles for article (PubMed ID: 37181678)
1. Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells.
Wuputra K; Lin CS; Tsai MH; Ku CC; Lin WH; Yang YH; Kuo KK; Yokoyama KK
Inflamm Regen; 2017; 37():15. PubMed ID: 29259714
[TBL] [Abstract][Full Text] [Related]
2. Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
Du J; Xu Y; Sasada S; Oo AKK; Hassan G; Mahmud H; Khayrani AC; Alam MJ; Kumon K; Uesaki R; Afify SM; Mansour HM; Nair N; Zahra MH; Seno A; Okada N; Chen L; Yan T; Seno M
Sci Rep; 2020 Jun; 10(1):9955. PubMed ID: 32572057
[TBL] [Abstract][Full Text] [Related]
3. MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway.
Hassan G; Afify SM; Du J; Nawara HM; Sheta M; Monzur S; Zahra MH; Abu Quora HA; Mansour H; El-Ghlban S; Uesaki R; Seno A; Seno M
Biochem Biophys Res Commun; 2021 Oct; 583():49-55. PubMed ID: 34735879
[TBL] [Abstract][Full Text] [Related]
4. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways.
Hassan G; Ohara T; Afify SM; Kumon K; Zahra MH; Fu X; Al Kadi M; Seno A; Salomon DS; Seno M
J Exp Clin Cancer Res; 2022 Jan; 41(1):29. PubMed ID: 35063003
[TBL] [Abstract][Full Text] [Related]
5. The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells.
Hassan G; Zahra MH; Seno A; Seno M
Sci Rep; 2022 Feb; 12(1):2711. PubMed ID: 35177646
[TBL] [Abstract][Full Text] [Related]
6. Method to Convert Stem Cells into Cancer Stem Cells.
Afify SM; Chen L; Yan T; Calle AS; Nair N; Murakami C; Zahra MH; Okada N; Iwasaki Y; Seno A; Seno M
Methods Protoc; 2019 Aug; 2(3):. PubMed ID: 31426391
[TBL] [Abstract][Full Text] [Related]
7. GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation.
Hassan G; Afify SM; Zahra MH; Nawara HM; Kumon K; Iwasaki Y; Salomon DS; Seno A; Seno M
Cytotechnology; 2023 Jun; 75(3):243-253. PubMed ID: 37181678
[TBL] [Abstract][Full Text] [Related]
8. Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.
Sarker DB; Xue Y; Mahmud F; Jocelyn JA; Sang QA
Cells; 2024 Jan; 13(2):. PubMed ID: 38247819
[TBL] [Abstract][Full Text] [Related]
9. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
Chanmee T; Ontong P; Kimata K; Itano N
Front Oncol; 2015; 5():180. PubMed ID: 26322272
[TBL] [Abstract][Full Text] [Related]
10. Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation.
Afify SM; Seno M
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862050
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
